Area of research
Immunology · Hematology
Research interest
Research interests include Immune Cell Function and Interaction, Acute Myeloid Leukemia Research, Virus-based gene therapy research, and CAR-T cell therapy research.
Human pluripotent stem cell-derived innate and adaptive immune cells for cancer immunotherapy.
No BCMA? No Problem: A CD70-Targeting CAR-NK Cell Shows Promise in High-risk Myeloma.
Human type-1 innate lymphoid cells control leukemia stem cell differentiation and limit acute myeloid leukemia development.
Optimizing In Vivo CAR T-cell Engineering for Cancer Immunotherapy.
Interim report on engineered NK cell trial in lung cancer refractory to immune checkpoint inhibitors
Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy.
CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors
Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice.
miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escape.
Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer.
NKp46 enhances type 1 innate lymphoid cell proliferation and function and anti-acute myeloid leukemia activity.
Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death
Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer.
The tumor-intrinsic role of the m <sup>6</sup> A reader YTHDF2 in regulating immune evasion
Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non-Small Cell Lung Cancer.
Supplementary Figure S1 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Table S1 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Figure S4 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Data from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Figure S5 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Figure S2 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Figure S4 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Figure S1 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Figure S5 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Figure S6 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Figure S2 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Table S1 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Figure S3 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Data from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer
Supplementary Figure S6 from Preclinical Evaluation of Off-The-Shelf PD-L1<sup>+</sup> Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer